โ Home
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights (2) ๐ข Company Q&A (574) ๐ ๏ธ Industry Q&A (121) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
| Date | Press release |
|---|---|
| 2026-03-06 09:00:00 | Zimmer Biomet Holdings, Inc. Investigated By The Portnoy Law Firm Los angeles, march 06, 2026 (globe newswire) -- the portnoy law firm advises zimmer biomet holdings, inc., (โzimmerโ or the โcompanyโ) (nyse:zbh) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. |
| 2026-02-25 07:06:00 | Zimmer Biomet To Release New Data, Highlight Key Innovations At American Academy Of Orthopaedic Surgeons Annual Meeting Companyโs chief movement officer, arnold schwarzenegger,will be presidential guest speaker warsaw,ย ind., feb. 25, 2026 /prnewswire/ --ย zimmer biomet holdings, inc. (nyse and six: zbh), a global medical technology leader, today announced it will unveil new clinical and operational data and showcase its newest innovations at the american academy of orthopaedic surgeons (aaos) 2026 annual meeting. |
| 2026-02-23 07:00:00 | Zimmer Biomet Announces Quarterly Dividend For First Quarter Of 2026 Warsaw,ย ind., feb. 23, 2026 /prnewswire/ --ย zimmer biomet holdings, inc. (nyse and six: zbh), a global medical technology leader, today announced that its board of directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026. |
| 2026-02-18 09:05:00 | Zbh Investor Alert: Hagens Berman Investigates Zimmer Biomet (zbh) Over Alleged Emerging Market Failures And \"inconsistent\" Execution Partner reed kathrein scrutinizing zbhโs โhigh confidenceโ assurances after 15% stock collapse and reduced revenue guidance san francisco, feb. 18, 2026 /prnewswire/ -- national shareholder rights law firm hagens berman is investigating zimmer biomet holdings, inc. (nyse: zbh) following a series of disclosures that calls into question the reasonable basis for the companyโs previously expressed โhigh confidenceโ in its 2025 revenue targets. the firm urges investors who suffered significant losses to submit your zbh losses now. |
| 2026-02-10 06:30:00 | Zimmer Biomet Announces Fourth Quarter And Full-year 2025 Financial Results Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basis fourth quarter diluted earnings per share were $0.70, a decrease of 41.7%; adjusted1 diluted earnings per share were $2.42, an increase of 4.8% full-year net sales of $8.232 billion increased 7.2% on a reported basis, 6.4% on a constant currency1 basis and 3.9% on an organic constant currency1 basis full-year diluted earnings per share were $3.55, a decrease of 19.9%; adjusted1 diluted earnings per share were $8.20, an increase of 2.5% company provides full-year 2026 financial guidance warsaw, ind., feb. 10, 2026 /prnewswire/ -- zimmer biomet holdings, inc. (nyse and six: zbh) today reported financial results for the quarter and year ended decemberย 31, 2025. |
| 2026-02-04 12:33:00 |
|
| 2026-01-30 12:20:00 |
|
| 2026-01-27 18:28:00 |
|
| 2026-01-23 13:17:00 |
|
| 2026-01-15 07:30:00 |
|
| 2025-12-22 07:30:00 |
|
| 2025-12-17 07:00:00 |
|
| 2025-12-16 07:30:00 |
|
| 2025-11-24 12:37:00 |
|
| 2025-11-20 16:29:00 |
|
๐ฐ Browse additional press releases for Zimmer Biomet!
Sign up for free or log in๐ Your free copy of "The Checklist Value Investor โ A Smarter Way to Pick Stocks" is waiting